skip to main content

ProfessionalsMarisa B. Geiger

Marisa B. Geiger

Tel: +1-212-373-3822
Fax: +1-212-492-0822

New York

1285 Avenue of the Americas
New York, NY 10019-6064
Fax: +1-212-492-0822

Bar Admissions 
Bar Admissions 

As counsel in Paul, Weiss’s Intellectual Property & Technology Transactions Group, Marisa Geiger focuses her practice on:

  • The intellectual property components of public and private mergers and acquisitions and other corporate transactions, such as asset and business line divestitures, minority investments and spin-outs
  • The structuring and negotiation of complex, standalone intellectual property transactions relating to the licensing, acquisition, development, transfer and exploitation of intellectual property, including in connection with collaboration arrangements, strategic alliances, distribution arrangements, long-term services arrangements and joint ventures
  • Settlements of intellectual property disputes and litigation
  • Providing strategic legal and business advice formulated to target complex intellectual property issues

Ms. Geiger has significant experience working with both financial and strategic clients in a broad range of industries, including the hardware, software, internet, telecommunications, social and digital media, semiconductor, manufacturing, life sciences, biotechnology, digital health, health services, professional services, education, content, leisure and hospitality, and consumer product industries.

Prior to joining Paul, Weiss, in addition to her involvement in negotiating a number of high-profile settlements of worldwide intellectual property disputes and confidential licensing, collaboration and development arrangements, she was involved in the intellectual property related components of numerous publicly reported transactions, including advising:

  • The Blackstone Group in its acquisition of a majority stake in ZO Skin Health, Inc., a premium California-based professional skincare brand
  • CLS Behring LLC, a global biotherapeutics company, in its up to $416 million acquisition of Calimmune, Inc., a privately held biotechnology company focused on the development of ex vivo ematopoietic stem cell (HSC) gene therapy
  • Eli Lilly and Company, a global pharmaceutical company, in its:
    • $1 billion acquisition of Prevail Therapeutics Inc., a publicly traded gene therapy company focused on the development of AAV-based gene therapies for patients with neurodegenerative diseases
    • its global exclusive licensing and research collaboration with, and equity investment in, Precision Biosciences, Inc., a clinical stage biotechnology company
  • Facebook in its $19 billion acquisition of WhatsApp, a mobile messaging service
  • Genstar Capital, a California based private equity firm, in its:
    • acquisition of Power Products Holdings LLC, a supplier and manufacturer of a diversified portfolio of branded aftermarket electrical systems and components
    • sales of Boyd Corporation (a global leader in thermal management and environmental sealing solutions), ConvergeOne Holdings Corp. (an independent provider of innovative communications solutions and managed services to enterprises globally) and Tecomet Inc. (a global provider of high-precision manufacturing solutions for complex, tight-tolerance products)
    • $910 million sale of the Global Marine and Mobile business of Power Products Holdings LLC
  • Koshidaka Holdings Co., Ltd. in the U.S. aspects its acquisition of Curves and Curves for Women II, L.C.
  • Magellan Health, Inc., a Fortune 500 company and leading provider of healthcare services, in its $2.2 billion merger with Centene Corporation
  • Merz North America, Inc., a specialty healthcare company with focuses on aesthetics, dermatology and neurosciences, in its:
    • $600 million acquisition of Ulthera, a global medical device company that commercializes an FDA-approved therapeutic ultrasound platform technology used for non-surgical skin lifts
    • Acquisition of On Light Sciences, Inc., a U.S. based medical device company that focuses on laser-based dermatologic procedures
  • Providence Equity Partners, a global private equity firm, in:
    • its acquisition of a majority stake in 365 Retail Markets LLC, a provider of end-to-end integrated SaaS software, payment processing and point of-sale hardware for the foodservice industry
    • the $635 million sale of Decision Resources, Inc., a provider of research, predictive analytics and consulting services to the healthcare industry
  • Quest Diagnostics Inc., a leading provider of diagnostic testing and information services, in its acquisitions of:
    • the U.S. laboratory services business of Oxford Immunotec Global PLCL, along with an associated long term supply arrangement for T-SPOT.TB test kits and related accessories
    • Blueprint Genetics, a specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics
  • Softbank Vision Fund in its:
    • $2.25 billion minority investment in GM Cruise Holdings LLC (Cruise), a U.S.-based autonomous driving vehicle company, alongside a $1.1 billion investment in Cruise by GM
    • $500 million minority investment in Cambridge Mobile Telematics, Inc., a mobile telematics and analytics provider
  • Twilio Inc., a cloud communications platform company, in its acquisition of Authy, Inc., a privately owned company that provides two-factor authentication services to end users, developers and enterprises
  • Yahoo! Inc. in:
    • its strategic acquisitions of, or asset acquisitions from, Tumblr, Inc., BrightRoll, Inc., Summly Limited, Flurry, Inc., MSKYNET, ThumbsUp Labs, Tomfoolery, Xobni Corporation,, UrbanQ, GhostBird Software, Inc., AdMovate, Inc., Hitpost, Cooliris and PTCH
    • the $4.5 billion sale of its operating business to Verizon Communications Inc.

Ms. Geiger has provided pro bono legal services on behalf of numerous clients, including the Lincoln Center for the Performing Arts, the Progeria Research Foundation, the National September 11 Memorial & Museum, the Breast Cancer Research Foundation and the Museum of Jewish Heritage.  Ms. Geiger completed a secondment under the head of the IP Transaction Group at Yahoo! Inc. in 2014, and served as a voting member on the IP Licensing Standards Committee of the Licensing Executives Society of USA and Canada from 2020-2021.

Awards and Recognitions

Recommended for Patents: Licensing by Legal 500 USA in 2021

IT & Outsourcing: Transactions (New York) – Named the only “Associate to Watch” by Chambers USA in 2019

© 2023 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy